Quadrant Capital Group’s Surgery Partners SGRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,000
| Closed | -$11.9K | – | 2347 |
|
|
2026
Q1 | $11.9K | Sell |
1,000
-94
| -9% | -$1.35K | ﹤0.01% | 2151 |
|
|
2025
Q4 | $16.9K | Sell |
1,094
-21
| -2% | -$386 | ﹤0.01% | 2057 |
|
|
2025
Q3 | $24.1K | Buy |
+1,115
| New | +$24.9K | ﹤0.01% | 1889 |
|
|
2025
Q2 | – | Sell |
-1,303
| Closed | -$30.9K | – | 2395 |
|
|
2025
Q1 | $30.9K | Buy |
1,303
+44
| +3% | +$1.04K | ﹤0.01% | 1890 |
|
|
2024
Q4 | $26.7K | Sell |
1,259
-136
| -10% | -$3.57K | ﹤0.01% | 1751 |
|
|
2024
Q3 | $45K | Buy |
1,395
+2
| +0.1% | +$59 | ﹤0.01% | 1507 |
|
|
2024
Q2 | $33.1K | Hold |
1,393
| – | – | ﹤0.01% | 1619 |
|
|
2024
Q1 | $41.6K | Hold |
1,393
| – | – | ﹤0.01% | 1501 |
|
|
2023
Q4 | $44.6K | Hold |
1,393
| – | – | ﹤0.01% | 1449 |
|
|
2023
Q3 | $40.7K | Hold |
1,393
| – | – | ﹤0.01% | 1375 |
|
|
2023
Q2 | $62.7K | Hold |
1,393
| – | – | 0.01% | 1138 |
|
|
2023
Q1 | $48K | Hold |
1,393
| – | – | 0.01% | 1263 |
|
|
2022
Q4 | $38.8K | Hold |
1,393
| – | – | ﹤0.01% | 1324 |
|
|
2022
Q3 | $33K | Hold |
1,393
| – | – | ﹤0.01% | 1273 |
|
|
2022
Q2 | $40K | Hold |
1,393
| – | – | 0.01% | 973 |
|
|
2022
Q1 | $77K | Hold |
1,393
| – | – | 0.01% | 776 |
|
|
2021
Q4 | $74K | Hold |
1,393
| – | – | 0.01% | 773 |
|
|
2021
Q3 | $59K | Hold |
1,393
| – | – | 0.01% | 801 |
|
|
2021
Q2 | $93K | Hold |
1,393
| – | – | 0.01% | 636 |
|
|
2021
Q1 | $62K | Hold |
1,393
| – | – | 0.01% | 736 |
|
|
2020
Q4 | $40K | Hold |
1,393
| – | – | 0.01% | 826 |
|
|
2020
Q3 | $31K | Hold |
1,393
| – | – | 0.01% | 807 |
|
|
2020
Q2 | $16K | Hold |
1,393
| – | – | ﹤0.01% | 1158 |
|
|
2020
Q1 | $9K | Hold |
1,393
| – | – | ﹤0.01% | 1476 |
|
|
2019
Q4 | $21K | Hold |
1,393
| – | – | ﹤0.01% | 1692 |
|
|
2019
Q3 | $10K | Buy |
+1,393
| New | +$9.97K | ﹤0.01% | 1760 |
|
|
2018
Q2 | – | Sell |
-198
| Closed | -$3K | – | 2196 |
|
|
2018
Q1 | $3K | Buy |
+198
| New | +$3.08K | ﹤0.01% | 1734 |
|
|
2017
Q3 | – | Sell |
-75
| Closed | -$1K | – | 2165 |
|
|
2017
Q2 | $1K | Hold |
75
| – | – | ﹤0.01% | 1753 |
|
|
2017
Q1 | $1K | Buy |
+75
| New | +$1.46K | ﹤0.01% | 1872 |
|
Other funds holding SGRY
BCI
JT
PCM
KSCM
Quadrant Capital Group's SGRY Position: Q2 2026 in Review
Quadrant Capital Group sold out of Surgery Partners (SGRY) in Q2 2026, closing a stake of 1,000 shares — an estimated $11.9K sold.
Quadrant Capital Group first reported a position in SGRY in Q1 2017 and held it in 29 quarters. The position peaked at $93K in Q2 2021. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.
- Quadrant Capital Group reported no remaining Surgery Partners position as of Q2 2026 after selling out during the quarter.
- Quadrant Capital Group sold 1,000 Surgery Partners shares in Q2 2026, an estimated $11.9K.
- Quadrant Capital Group first reported a position in Surgery Partners in Q1 2017 and held it in 29 quarters.
- Quadrant Capital Group's Surgery Partners position peaked at $93K in Q2 2021.
- 187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.
Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.